nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP3A4—prostate cancer	0.144	1	CbGaD
Tramadol—CYP2B6—Estrone—prostate cancer	0.0477	0.118	CbGbCtD
Tramadol—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0466	0.115	CbGbCtD
Tramadol—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0425	0.105	CbGbCtD
Tramadol—CYP2D6—Bicalutamide—prostate cancer	0.0385	0.0952	CbGbCtD
Tramadol—CYP2D6—Abiraterone—prostate cancer	0.0319	0.0789	CbGbCtD
Tramadol—CYP3A4—Bicalutamide—prostate cancer	0.0245	0.0606	CbGbCtD
Tramadol—CYP3A4—Estramustine—prostate cancer	0.0228	0.0563	CbGbCtD
Tramadol—CYP3A4—Abiraterone—prostate cancer	0.0203	0.0502	CbGbCtD
Tramadol—CYP3A4—Flutamide—prostate cancer	0.0203	0.0502	CbGbCtD
Tramadol—CYP3A4—Cabazitaxel—prostate cancer	0.015	0.0371	CbGbCtD
Tramadol—CYP3A4—Estrone—prostate cancer	0.0147	0.0363	CbGbCtD
Tramadol—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0131	0.0323	CbGbCtD
Tramadol—CYP2B6—Doxorubicin—prostate cancer	0.0122	0.0302	CbGbCtD
Tramadol—CHRM3—ureter—prostate cancer	0.00971	0.389	CbGeAlD
Tramadol—CYP3A4—Conjugated Estrogens—prostate cancer	0.00959	0.0237	CbGbCtD
Tramadol—CYP3A4—Mitoxantrone—prostate cancer	0.00872	0.0216	CbGbCtD
Tramadol—CYP3A4—Estradiol—prostate cancer	0.00842	0.0208	CbGbCtD
Tramadol—CYP3A4—Prednisone—prostate cancer	0.00724	0.0179	CbGbCtD
Tramadol—CYP2D6—Doxorubicin—prostate cancer	0.0059	0.0146	CbGbCtD
Tramadol—CYP3A4—Etoposide—prostate cancer	0.0055	0.0136	CbGbCtD
Tramadol—CYP3A4—Docetaxel—prostate cancer	0.00503	0.0124	CbGbCtD
Tramadol—CYP3A4—Doxorubicin—prostate cancer	0.00375	0.00928	CbGbCtD
Tramadol—Dextromethorphan—PGRMC1—prostate cancer	0.00319	0.587	CrCbGaD
Tramadol—OPRK1—prostate gland—prostate cancer	0.00215	0.0861	CbGeAlD
Tramadol—CYP3A4—urine—prostate cancer	0.00173	0.0695	CbGeAlD
Tramadol—CYP2D6—urine—prostate cancer	0.00171	0.0684	CbGeAlD
Tramadol—OPRD1—renal system—prostate cancer	0.00153	0.0612	CbGeAlD
Tramadol—GRIN3A—testis—prostate cancer	0.0014	0.0561	CbGeAlD
Tramadol—CHRM3—prostate gland—prostate cancer	0.00113	0.0454	CbGeAlD
Tramadol—CHRM3—renal system—prostate cancer	0.000772	0.0309	CbGeAlD
Tramadol—CHRM3—urethra—prostate cancer	0.000758	0.0304	CbGeAlD
Tramadol—OPRM1—testis—prostate cancer	0.000673	0.027	CbGeAlD
Tramadol—Venlafaxine—CYP2C19—prostate cancer	0.000653	0.12	CrCbGaD
Tramadol—CYP2B6—renal system—prostate cancer	0.000562	0.0225	CbGeAlD
Tramadol—CHRM3—testis—prostate cancer	0.000499	0.02	CbGeAlD
Tramadol—SLC6A2—testis—prostate cancer	0.000493	0.0197	CbGeAlD
Tramadol—CYP3A4—renal system—prostate cancer	0.000424	0.017	CbGeAlD
Tramadol—Dextromethorphan—CYP3A5—prostate cancer	0.00042	0.0773	CrCbGaD
Tramadol—CYP2D6—renal system—prostate cancer	0.000418	0.0167	CbGeAlD
Tramadol—Venlafaxine—CYP3A4—prostate cancer	0.000415	0.0764	CrCbGaD
Tramadol—CYP2B6—testis—prostate cancer	0.000363	0.0146	CbGeAlD
Tramadol—SLC6A2—lymph node—prostate cancer	0.000357	0.0143	CbGeAlD
Tramadol—Dextromethorphan—CYP2E1—prostate cancer	0.000289	0.0531	CrCbGaD
Tramadol—Dextromethorphan—CYP2C19—prostate cancer	0.000286	0.0526	CrCbGaD
Tramadol—CYP2D6—testis—prostate cancer	0.00027	0.0108	CbGeAlD
Tramadol—Dextromethorphan—CYP3A4—prostate cancer	0.000182	0.0335	CrCbGaD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.72e-05	8.8e-05	CcSEcCtD
Tramadol—Dyspnoea—Docetaxel—prostate cancer	2.71e-05	8.78e-05	CcSEcCtD
Tramadol—Somnolence—Docetaxel—prostate cancer	2.71e-05	8.75e-05	CcSEcCtD
Tramadol—Discomfort—Prednisone—prostate cancer	2.7e-05	8.75e-05	CcSEcCtD
Tramadol—Eye disorder—Epirubicin—prostate cancer	2.7e-05	8.74e-05	CcSEcCtD
Tramadol—Hypersensitivity—Etoposide—prostate cancer	2.7e-05	8.73e-05	CcSEcCtD
Tramadol—Tinnitus—Epirubicin—prostate cancer	2.69e-05	8.71e-05	CcSEcCtD
Tramadol—Haemoglobin—Doxorubicin—prostate cancer	2.69e-05	8.69e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.68e-05	8.68e-05	CcSEcCtD
Tramadol—Cardiac disorder—Epirubicin—prostate cancer	2.68e-05	8.67e-05	CcSEcCtD
Tramadol—Flushing—Epirubicin—prostate cancer	2.68e-05	8.67e-05	CcSEcCtD
Tramadol—Rhinitis—Doxorubicin—prostate cancer	2.68e-05	8.67e-05	CcSEcCtD
Tramadol—Dyspepsia—Docetaxel—prostate cancer	2.68e-05	8.67e-05	CcSEcCtD
Tramadol—Haemorrhage—Doxorubicin—prostate cancer	2.67e-05	8.65e-05	CcSEcCtD
Tramadol—Hepatitis—Doxorubicin—prostate cancer	2.67e-05	8.65e-05	CcSEcCtD
Tramadol—Insomnia—Capecitabine—prostate cancer	2.66e-05	8.62e-05	CcSEcCtD
Tramadol—Hypoaesthesia—Doxorubicin—prostate cancer	2.66e-05	8.61e-05	CcSEcCtD
Tramadol—Pharyngitis—Doxorubicin—prostate cancer	2.65e-05	8.58e-05	CcSEcCtD
Tramadol—Paraesthesia—Capecitabine—prostate cancer	2.65e-05	8.56e-05	CcSEcCtD
Tramadol—Decreased appetite—Docetaxel—prostate cancer	2.65e-05	8.56e-05	CcSEcCtD
Tramadol—Urinary tract disorder—Doxorubicin—prostate cancer	2.64e-05	8.54e-05	CcSEcCtD
Tramadol—Oedema peripheral—Doxorubicin—prostate cancer	2.63e-05	8.52e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Docetaxel—prostate cancer	2.63e-05	8.5e-05	CcSEcCtD
Tramadol—Asthenia—Etoposide—prostate cancer	2.63e-05	8.5e-05	CcSEcCtD
Tramadol—Connective tissue disorder—Doxorubicin—prostate cancer	2.63e-05	8.5e-05	CcSEcCtD
Tramadol—Dyspnoea—Capecitabine—prostate cancer	2.63e-05	8.5e-05	CcSEcCtD
Tramadol—Anaphylactic shock—Prednisone—prostate cancer	2.62e-05	8.49e-05	CcSEcCtD
Tramadol—Fatigue—Docetaxel—prostate cancer	2.62e-05	8.49e-05	CcSEcCtD
Tramadol—Angiopathy—Epirubicin—prostate cancer	2.62e-05	8.48e-05	CcSEcCtD
Tramadol—Urethral disorder—Doxorubicin—prostate cancer	2.62e-05	8.48e-05	CcSEcCtD
Tramadol—Nausea—Mitoxantrone—prostate cancer	2.61e-05	8.46e-05	CcSEcCtD
Tramadol—Immune system disorder—Epirubicin—prostate cancer	2.61e-05	8.44e-05	CcSEcCtD
Tramadol—Infection—Prednisone—prostate cancer	2.61e-05	8.44e-05	CcSEcCtD
Tramadol—Mediastinal disorder—Epirubicin—prostate cancer	2.6e-05	8.42e-05	CcSEcCtD
Tramadol—Pain—Docetaxel—prostate cancer	2.6e-05	8.42e-05	CcSEcCtD
Tramadol—Constipation—Docetaxel—prostate cancer	2.6e-05	8.42e-05	CcSEcCtD
Tramadol—Dyspepsia—Capecitabine—prostate cancer	2.59e-05	8.39e-05	CcSEcCtD
Tramadol—Chills—Epirubicin—prostate cancer	2.59e-05	8.39e-05	CcSEcCtD
Tramadol—Pruritus—Etoposide—prostate cancer	2.59e-05	8.38e-05	CcSEcCtD
Tramadol—Shock—Prednisone—prostate cancer	2.58e-05	8.35e-05	CcSEcCtD
Tramadol—Arrhythmia—Epirubicin—prostate cancer	2.58e-05	8.35e-05	CcSEcCtD
Tramadol—Visual impairment—Doxorubicin—prostate cancer	2.58e-05	8.33e-05	CcSEcCtD
Tramadol—Nervous system disorder—Prednisone—prostate cancer	2.57e-05	8.33e-05	CcSEcCtD
Tramadol—Tachycardia—Prednisone—prostate cancer	2.56e-05	8.29e-05	CcSEcCtD
Tramadol—Decreased appetite—Capecitabine—prostate cancer	2.56e-05	8.29e-05	CcSEcCtD
Tramadol—Skin disorder—Prednisone—prostate cancer	2.55e-05	8.25e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Capecitabine—prostate cancer	2.54e-05	8.23e-05	CcSEcCtD
Tramadol—Fatigue—Capecitabine—prostate cancer	2.54e-05	8.22e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Prednisone—prostate cancer	2.54e-05	8.21e-05	CcSEcCtD
Tramadol—Mental disorder—Epirubicin—prostate cancer	2.53e-05	8.19e-05	CcSEcCtD
Tramadol—Erythema multiforme—Doxorubicin—prostate cancer	2.53e-05	8.18e-05	CcSEcCtD
Tramadol—Pain—Capecitabine—prostate cancer	2.52e-05	8.15e-05	CcSEcCtD
Tramadol—Constipation—Capecitabine—prostate cancer	2.52e-05	8.15e-05	CcSEcCtD
Tramadol—Erythema—Epirubicin—prostate cancer	2.51e-05	8.14e-05	CcSEcCtD
Tramadol—Malnutrition—Epirubicin—prostate cancer	2.51e-05	8.14e-05	CcSEcCtD
Tramadol—Feeling abnormal—Docetaxel—prostate cancer	2.51e-05	8.11e-05	CcSEcCtD
Tramadol—Diarrhoea—Etoposide—prostate cancer	2.51e-05	8.11e-05	CcSEcCtD
Tramadol—Anorexia—Prednisone—prostate cancer	2.5e-05	8.09e-05	CcSEcCtD
Tramadol—Eye disorder—Doxorubicin—prostate cancer	2.5e-05	8.08e-05	CcSEcCtD
Tramadol—Tinnitus—Doxorubicin—prostate cancer	2.49e-05	8.06e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Docetaxel—prostate cancer	2.49e-05	8.05e-05	CcSEcCtD
Tramadol—Cardiac disorder—Doxorubicin—prostate cancer	2.48e-05	8.03e-05	CcSEcCtD
Tramadol—Flushing—Doxorubicin—prostate cancer	2.48e-05	8.03e-05	CcSEcCtD
Tramadol—Flatulence—Epirubicin—prostate cancer	2.48e-05	8.02e-05	CcSEcCtD
Tramadol—Tension—Epirubicin—prostate cancer	2.47e-05	7.98e-05	CcSEcCtD
Tramadol—Dysgeusia—Epirubicin—prostate cancer	2.46e-05	7.97e-05	CcSEcCtD
Tramadol—Nervousness—Epirubicin—prostate cancer	2.44e-05	7.9e-05	CcSEcCtD
Tramadol—Back pain—Epirubicin—prostate cancer	2.43e-05	7.87e-05	CcSEcCtD
Tramadol—Feeling abnormal—Capecitabine—prostate cancer	2.43e-05	7.86e-05	CcSEcCtD
Tramadol—Angiopathy—Doxorubicin—prostate cancer	2.43e-05	7.85e-05	CcSEcCtD
Tramadol—Dizziness—Etoposide—prostate cancer	2.42e-05	7.83e-05	CcSEcCtD
Tramadol—Muscle spasms—Epirubicin—prostate cancer	2.42e-05	7.82e-05	CcSEcCtD
Tramadol—Immune system disorder—Doxorubicin—prostate cancer	2.41e-05	7.81e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Capecitabine—prostate cancer	2.41e-05	7.79e-05	CcSEcCtD
Tramadol—Mediastinal disorder—Doxorubicin—prostate cancer	2.41e-05	7.79e-05	CcSEcCtD
Tramadol—Abdominal pain—Docetaxel—prostate cancer	2.41e-05	7.78e-05	CcSEcCtD
Tramadol—Body temperature increased—Docetaxel—prostate cancer	2.41e-05	7.78e-05	CcSEcCtD
Tramadol—Chills—Doxorubicin—prostate cancer	2.4e-05	7.76e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Prednisone—prostate cancer	2.39e-05	7.74e-05	CcSEcCtD
Tramadol—Arrhythmia—Doxorubicin—prostate cancer	2.39e-05	7.73e-05	CcSEcCtD
Tramadol—Insomnia—Prednisone—prostate cancer	2.37e-05	7.68e-05	CcSEcCtD
Tramadol—Vision blurred—Epirubicin—prostate cancer	2.37e-05	7.67e-05	CcSEcCtD
Tramadol—Paraesthesia—Prednisone—prostate cancer	2.36e-05	7.62e-05	CcSEcCtD
Tramadol—Mental disorder—Doxorubicin—prostate cancer	2.34e-05	7.58e-05	CcSEcCtD
Tramadol—Urticaria—Capecitabine—prostate cancer	2.34e-05	7.57e-05	CcSEcCtD
Tramadol—Ill-defined disorder—Epirubicin—prostate cancer	2.33e-05	7.55e-05	CcSEcCtD
Tramadol—Abdominal pain—Capecitabine—prostate cancer	2.33e-05	7.54e-05	CcSEcCtD
Tramadol—Body temperature increased—Capecitabine—prostate cancer	2.33e-05	7.54e-05	CcSEcCtD
Tramadol—Vomiting—Etoposide—prostate cancer	2.33e-05	7.53e-05	CcSEcCtD
Tramadol—Malnutrition—Doxorubicin—prostate cancer	2.33e-05	7.53e-05	CcSEcCtD
Tramadol—Erythema—Doxorubicin—prostate cancer	2.33e-05	7.53e-05	CcSEcCtD
Tramadol—Anaemia—Epirubicin—prostate cancer	2.32e-05	7.52e-05	CcSEcCtD
Tramadol—Agitation—Epirubicin—prostate cancer	2.31e-05	7.48e-05	CcSEcCtD
Tramadol—Dyspepsia—Prednisone—prostate cancer	2.31e-05	7.47e-05	CcSEcCtD
Tramadol—Rash—Etoposide—prostate cancer	2.31e-05	7.47e-05	CcSEcCtD
Tramadol—Dermatitis—Etoposide—prostate cancer	2.31e-05	7.46e-05	CcSEcCtD
Tramadol—Headache—Etoposide—prostate cancer	2.29e-05	7.42e-05	CcSEcCtD
Tramadol—Flatulence—Doxorubicin—prostate cancer	2.29e-05	7.42e-05	CcSEcCtD
Tramadol—Tension—Doxorubicin—prostate cancer	2.28e-05	7.39e-05	CcSEcCtD
Tramadol—Decreased appetite—Prednisone—prostate cancer	2.28e-05	7.38e-05	CcSEcCtD
Tramadol—Dysgeusia—Doxorubicin—prostate cancer	2.28e-05	7.37e-05	CcSEcCtD
Tramadol—Malaise—Epirubicin—prostate cancer	2.27e-05	7.34e-05	CcSEcCtD
Tramadol—Fatigue—Prednisone—prostate cancer	2.26e-05	7.32e-05	CcSEcCtD
Tramadol—Nervousness—Doxorubicin—prostate cancer	2.26e-05	7.31e-05	CcSEcCtD
Tramadol—Vertigo—Epirubicin—prostate cancer	2.26e-05	7.31e-05	CcSEcCtD
Tramadol—Syncope—Epirubicin—prostate cancer	2.26e-05	7.3e-05	CcSEcCtD
Tramadol—Back pain—Doxorubicin—prostate cancer	2.25e-05	7.28e-05	CcSEcCtD
Tramadol—Constipation—Prednisone—prostate cancer	2.24e-05	7.26e-05	CcSEcCtD
Tramadol—Hypersensitivity—Docetaxel—prostate cancer	2.24e-05	7.25e-05	CcSEcCtD
Tramadol—Muscle spasms—Doxorubicin—prostate cancer	2.24e-05	7.24e-05	CcSEcCtD
Tramadol—Palpitations—Epirubicin—prostate cancer	2.22e-05	7.19e-05	CcSEcCtD
Tramadol—Loss of consciousness—Epirubicin—prostate cancer	2.21e-05	7.15e-05	CcSEcCtD
Tramadol—Cough—Epirubicin—prostate cancer	2.19e-05	7.1e-05	CcSEcCtD
Tramadol—Vision blurred—Doxorubicin—prostate cancer	2.19e-05	7.1e-05	CcSEcCtD
Tramadol—Asthenia—Docetaxel—prostate cancer	2.18e-05	7.06e-05	CcSEcCtD
Tramadol—Convulsion—Epirubicin—prostate cancer	2.18e-05	7.05e-05	CcSEcCtD
Tramadol—Nausea—Etoposide—prostate cancer	2.17e-05	7.04e-05	CcSEcCtD
Tramadol—Hypertension—Epirubicin—prostate cancer	2.17e-05	7.03e-05	CcSEcCtD
Tramadol—Hypersensitivity—Capecitabine—prostate cancer	2.17e-05	7.02e-05	CcSEcCtD
Tramadol—Feeling abnormal—Prednisone—prostate cancer	2.16e-05	7e-05	CcSEcCtD
Tramadol—Ill-defined disorder—Doxorubicin—prostate cancer	2.16e-05	6.99e-05	CcSEcCtD
Tramadol—Pruritus—Docetaxel—prostate cancer	2.15e-05	6.97e-05	CcSEcCtD
Tramadol—Anaemia—Doxorubicin—prostate cancer	2.15e-05	6.96e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Prednisone—prostate cancer	2.15e-05	6.94e-05	CcSEcCtD
Tramadol—Arthralgia—Epirubicin—prostate cancer	2.14e-05	6.93e-05	CcSEcCtD
Tramadol—Chest pain—Epirubicin—prostate cancer	2.14e-05	6.93e-05	CcSEcCtD
Tramadol—Myalgia—Epirubicin—prostate cancer	2.14e-05	6.93e-05	CcSEcCtD
Tramadol—Agitation—Doxorubicin—prostate cancer	2.14e-05	6.92e-05	CcSEcCtD
Tramadol—Anxiety—Epirubicin—prostate cancer	2.13e-05	6.9e-05	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.13e-05	6.88e-05	CcSEcCtD
Tramadol—Discomfort—Epirubicin—prostate cancer	2.12e-05	6.84e-05	CcSEcCtD
Tramadol—Asthenia—Capecitabine—prostate cancer	2.11e-05	6.84e-05	CcSEcCtD
Tramadol—Malaise—Doxorubicin—prostate cancer	2.1e-05	6.79e-05	CcSEcCtD
Tramadol—Dry mouth—Epirubicin—prostate cancer	2.09e-05	6.77e-05	CcSEcCtD
Tramadol—Vertigo—Doxorubicin—prostate cancer	2.09e-05	6.76e-05	CcSEcCtD
Tramadol—Syncope—Doxorubicin—prostate cancer	2.09e-05	6.75e-05	CcSEcCtD
Tramadol—Urticaria—Prednisone—prostate cancer	2.08e-05	6.75e-05	CcSEcCtD
Tramadol—Pruritus—Capecitabine—prostate cancer	2.08e-05	6.74e-05	CcSEcCtD
Tramadol—Diarrhoea—Docetaxel—prostate cancer	2.08e-05	6.74e-05	CcSEcCtD
Tramadol—Body temperature increased—Prednisone—prostate cancer	2.07e-05	6.71e-05	CcSEcCtD
Tramadol—Abdominal pain—Prednisone—prostate cancer	2.07e-05	6.71e-05	CcSEcCtD
Tramadol—Confusional state—Epirubicin—prostate cancer	2.07e-05	6.7e-05	CcSEcCtD
Tramadol—Palpitations—Doxorubicin—prostate cancer	2.06e-05	6.65e-05	CcSEcCtD
Tramadol—Anaphylactic shock—Epirubicin—prostate cancer	2.05e-05	6.64e-05	CcSEcCtD
Tramadol—Loss of consciousness—Doxorubicin—prostate cancer	2.05e-05	6.62e-05	CcSEcCtD
Tramadol—Infection—Epirubicin—prostate cancer	2.04e-05	6.6e-05	CcSEcCtD
Tramadol—Cough—Doxorubicin—prostate cancer	2.03e-05	6.57e-05	CcSEcCtD
Tramadol—Shock—Epirubicin—prostate cancer	2.02e-05	6.53e-05	CcSEcCtD
Tramadol—Convulsion—Doxorubicin—prostate cancer	2.02e-05	6.52e-05	CcSEcCtD
Tramadol—Diarrhoea—Capecitabine—prostate cancer	2.02e-05	6.52e-05	CcSEcCtD
Tramadol—Nervous system disorder—Epirubicin—prostate cancer	2.01e-05	6.51e-05	CcSEcCtD
Tramadol—Dizziness—Docetaxel—prostate cancer	2.01e-05	6.51e-05	CcSEcCtD
Tramadol—Thrombocytopenia—Epirubicin—prostate cancer	2.01e-05	6.5e-05	CcSEcCtD
Tramadol—Hypertension—Doxorubicin—prostate cancer	2.01e-05	6.5e-05	CcSEcCtD
Tramadol—Tachycardia—Epirubicin—prostate cancer	2e-05	6.48e-05	CcSEcCtD
Tramadol—Skin disorder—Epirubicin—prostate cancer	1.99e-05	6.45e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Epirubicin—prostate cancer	1.98e-05	6.42e-05	CcSEcCtD
Tramadol—Arthralgia—Doxorubicin—prostate cancer	1.98e-05	6.41e-05	CcSEcCtD
Tramadol—Chest pain—Doxorubicin—prostate cancer	1.98e-05	6.41e-05	CcSEcCtD
Tramadol—Myalgia—Doxorubicin—prostate cancer	1.98e-05	6.41e-05	CcSEcCtD
Tramadol—Anxiety—Doxorubicin—prostate cancer	1.97e-05	6.39e-05	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.97e-05	6.37e-05	CcSEcCtD
Tramadol—Discomfort—Doxorubicin—prostate cancer	1.96e-05	6.33e-05	CcSEcCtD
Tramadol—Anorexia—Epirubicin—prostate cancer	1.96e-05	6.33e-05	CcSEcCtD
Tramadol—Dizziness—Capecitabine—prostate cancer	1.95e-05	6.3e-05	CcSEcCtD
Tramadol—Dry mouth—Doxorubicin—prostate cancer	1.94e-05	6.27e-05	CcSEcCtD
Tramadol—Vomiting—Docetaxel—prostate cancer	1.93e-05	6.26e-05	CcSEcCtD
Tramadol—Hypersensitivity—Prednisone—prostate cancer	1.93e-05	6.26e-05	CcSEcCtD
Tramadol—Rash—Docetaxel—prostate cancer	1.92e-05	6.21e-05	CcSEcCtD
Tramadol—Hypotension—Epirubicin—prostate cancer	1.92e-05	6.21e-05	CcSEcCtD
Tramadol—Dermatitis—Docetaxel—prostate cancer	1.92e-05	6.2e-05	CcSEcCtD
Tramadol—Confusional state—Doxorubicin—prostate cancer	1.91e-05	6.2e-05	CcSEcCtD
Tramadol—Headache—Docetaxel—prostate cancer	1.91e-05	6.17e-05	CcSEcCtD
Tramadol—Anaphylactic shock—Doxorubicin—prostate cancer	1.9e-05	6.14e-05	CcSEcCtD
Tramadol—Infection—Doxorubicin—prostate cancer	1.89e-05	6.1e-05	CcSEcCtD
Tramadol—Asthenia—Prednisone—prostate cancer	1.88e-05	6.09e-05	CcSEcCtD
Tramadol—Vomiting—Capecitabine—prostate cancer	1.87e-05	6.06e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.87e-05	6.05e-05	CcSEcCtD
Tramadol—Shock—Doxorubicin—prostate cancer	1.87e-05	6.05e-05	CcSEcCtD
Tramadol—Nervous system disorder—Doxorubicin—prostate cancer	1.86e-05	6.03e-05	CcSEcCtD
Tramadol—Thrombocytopenia—Doxorubicin—prostate cancer	1.86e-05	6.02e-05	CcSEcCtD
Tramadol—Rash—Capecitabine—prostate cancer	1.86e-05	6.01e-05	CcSEcCtD
Tramadol—Pruritus—Prednisone—prostate cancer	1.86e-05	6.01e-05	CcSEcCtD
Tramadol—Insomnia—Epirubicin—prostate cancer	1.86e-05	6.01e-05	CcSEcCtD
Tramadol—Dermatitis—Capecitabine—prostate cancer	1.86e-05	6e-05	CcSEcCtD
Tramadol—Tachycardia—Doxorubicin—prostate cancer	1.85e-05	6e-05	CcSEcCtD
Tramadol—Headache—Capecitabine—prostate cancer	1.85e-05	5.97e-05	CcSEcCtD
Tramadol—Skin disorder—Doxorubicin—prostate cancer	1.84e-05	5.97e-05	CcSEcCtD
Tramadol—Paraesthesia—Epirubicin—prostate cancer	1.84e-05	5.96e-05	CcSEcCtD
Tramadol—Hyperhidrosis—Doxorubicin—prostate cancer	1.84e-05	5.94e-05	CcSEcCtD
Tramadol—Dyspnoea—Epirubicin—prostate cancer	1.83e-05	5.92e-05	CcSEcCtD
Tramadol—Somnolence—Epirubicin—prostate cancer	1.82e-05	5.9e-05	CcSEcCtD
Tramadol—Anorexia—Doxorubicin—prostate cancer	1.81e-05	5.86e-05	CcSEcCtD
Tramadol—Nausea—Docetaxel—prostate cancer	1.81e-05	5.85e-05	CcSEcCtD
Tramadol—Dyspepsia—Epirubicin—prostate cancer	1.81e-05	5.85e-05	CcSEcCtD
Tramadol—Diarrhoea—Prednisone—prostate cancer	1.8e-05	5.81e-05	CcSEcCtD
Tramadol—Decreased appetite—Epirubicin—prostate cancer	1.78e-05	5.77e-05	CcSEcCtD
Tramadol—Hypotension—Doxorubicin—prostate cancer	1.77e-05	5.74e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Epirubicin—prostate cancer	1.77e-05	5.73e-05	CcSEcCtD
Tramadol—Fatigue—Epirubicin—prostate cancer	1.77e-05	5.73e-05	CcSEcCtD
Tramadol—Pain—Epirubicin—prostate cancer	1.76e-05	5.68e-05	CcSEcCtD
Tramadol—Constipation—Epirubicin—prostate cancer	1.76e-05	5.68e-05	CcSEcCtD
Tramadol—Nausea—Capecitabine—prostate cancer	1.75e-05	5.66e-05	CcSEcCtD
Tramadol—Dizziness—Prednisone—prostate cancer	1.74e-05	5.61e-05	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.73e-05	5.6e-05	CcSEcCtD
Tramadol—Insomnia—Doxorubicin—prostate cancer	1.72e-05	5.56e-05	CcSEcCtD
Tramadol—Paraesthesia—Doxorubicin—prostate cancer	1.71e-05	5.52e-05	CcSEcCtD
Tramadol—Dyspnoea—Doxorubicin—prostate cancer	1.69e-05	5.48e-05	CcSEcCtD
Tramadol—Feeling abnormal—Epirubicin—prostate cancer	1.69e-05	5.47e-05	CcSEcCtD
Tramadol—Somnolence—Doxorubicin—prostate cancer	1.69e-05	5.46e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Epirubicin—prostate cancer	1.68e-05	5.43e-05	CcSEcCtD
Tramadol—Dyspepsia—Doxorubicin—prostate cancer	1.67e-05	5.41e-05	CcSEcCtD
Tramadol—Vomiting—Prednisone—prostate cancer	1.67e-05	5.4e-05	CcSEcCtD
Tramadol—Rash—Prednisone—prostate cancer	1.65e-05	5.35e-05	CcSEcCtD
Tramadol—Dermatitis—Prednisone—prostate cancer	1.65e-05	5.35e-05	CcSEcCtD
Tramadol—Decreased appetite—Doxorubicin—prostate cancer	1.65e-05	5.34e-05	CcSEcCtD
Tramadol—Headache—Prednisone—prostate cancer	1.64e-05	5.32e-05	CcSEcCtD
Tramadol—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.64e-05	5.3e-05	CcSEcCtD
Tramadol—Fatigue—Doxorubicin—prostate cancer	1.64e-05	5.3e-05	CcSEcCtD
Tramadol—Urticaria—Epirubicin—prostate cancer	1.63e-05	5.28e-05	CcSEcCtD
Tramadol—Constipation—Doxorubicin—prostate cancer	1.62e-05	5.25e-05	CcSEcCtD
Tramadol—Pain—Doxorubicin—prostate cancer	1.62e-05	5.25e-05	CcSEcCtD
Tramadol—Body temperature increased—Epirubicin—prostate cancer	1.62e-05	5.25e-05	CcSEcCtD
Tramadol—Abdominal pain—Epirubicin—prostate cancer	1.62e-05	5.25e-05	CcSEcCtD
Tramadol—Feeling abnormal—Doxorubicin—prostate cancer	1.56e-05	5.06e-05	CcSEcCtD
Tramadol—Nausea—Prednisone—prostate cancer	1.56e-05	5.04e-05	CcSEcCtD
Tramadol—Gastrointestinal pain—Doxorubicin—prostate cancer	1.55e-05	5.02e-05	CcSEcCtD
Tramadol—Hypersensitivity—Epirubicin—prostate cancer	1.51e-05	4.89e-05	CcSEcCtD
Tramadol—Urticaria—Doxorubicin—prostate cancer	1.51e-05	4.88e-05	CcSEcCtD
Tramadol—Abdominal pain—Doxorubicin—prostate cancer	1.5e-05	4.86e-05	CcSEcCtD
Tramadol—Body temperature increased—Doxorubicin—prostate cancer	1.5e-05	4.86e-05	CcSEcCtD
Tramadol—Asthenia—Epirubicin—prostate cancer	1.47e-05	4.76e-05	CcSEcCtD
Tramadol—Pruritus—Epirubicin—prostate cancer	1.45e-05	4.7e-05	CcSEcCtD
Tramadol—Diarrhoea—Epirubicin—prostate cancer	1.4e-05	4.54e-05	CcSEcCtD
Tramadol—Hypersensitivity—Doxorubicin—prostate cancer	1.4e-05	4.53e-05	CcSEcCtD
Tramadol—Asthenia—Doxorubicin—prostate cancer	1.36e-05	4.41e-05	CcSEcCtD
Tramadol—Dizziness—Epirubicin—prostate cancer	1.36e-05	4.39e-05	CcSEcCtD
Tramadol—Pruritus—Doxorubicin—prostate cancer	1.34e-05	4.35e-05	CcSEcCtD
Tramadol—Vomiting—Epirubicin—prostate cancer	1.3e-05	4.22e-05	CcSEcCtD
Tramadol—Diarrhoea—Doxorubicin—prostate cancer	1.3e-05	4.2e-05	CcSEcCtD
Tramadol—Rash—Epirubicin—prostate cancer	1.29e-05	4.19e-05	CcSEcCtD
Tramadol—Dermatitis—Epirubicin—prostate cancer	1.29e-05	4.18e-05	CcSEcCtD
Tramadol—Headache—Epirubicin—prostate cancer	1.29e-05	4.16e-05	CcSEcCtD
Tramadol—Dizziness—Doxorubicin—prostate cancer	1.26e-05	4.06e-05	CcSEcCtD
Tramadol—Nausea—Epirubicin—prostate cancer	1.22e-05	3.94e-05	CcSEcCtD
Tramadol—Vomiting—Doxorubicin—prostate cancer	1.21e-05	3.91e-05	CcSEcCtD
Tramadol—Rash—Doxorubicin—prostate cancer	1.2e-05	3.87e-05	CcSEcCtD
Tramadol—Dermatitis—Doxorubicin—prostate cancer	1.2e-05	3.87e-05	CcSEcCtD
Tramadol—Headache—Doxorubicin—prostate cancer	1.19e-05	3.85e-05	CcSEcCtD
Tramadol—Nausea—Doxorubicin—prostate cancer	1.13e-05	3.65e-05	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—CDKN1B—prostate cancer	4.59e-06	4.09e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NCOA1—prostate cancer	4.58e-06	4.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGF—prostate cancer	4.58e-06	4.08e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IRS1—prostate cancer	4.58e-06	4.08e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FGF2—prostate cancer	4.54e-06	4.04e-05	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—AKT1—prostate cancer	4.54e-06	4.04e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.53e-06	4.04e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HIF1A—prostate cancer	4.53e-06	4.03e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.52e-06	4.02e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—INS—prostate cancer	4.51e-06	4.02e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CAV1—prostate cancer	4.5e-06	4.01e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CASP3—prostate cancer	4.5e-06	4.01e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—prostate cancer	4.49e-06	4e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOS3—prostate cancer	4.48e-06	3.99e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—SRC—prostate cancer	4.47e-06	3.98e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—prostate cancer	4.47e-06	3.98e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MED12—prostate cancer	4.46e-06	3.97e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—GSK3B—prostate cancer	4.44e-06	3.96e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GNG5—prostate cancer	4.42e-06	3.94e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CREBBP—prostate cancer	4.42e-06	3.94e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LEP—prostate cancer	4.42e-06	3.94e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—INS—prostate cancer	4.38e-06	3.9e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCND1—prostate cancer	4.38e-06	3.9e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CAV1—prostate cancer	4.38e-06	3.9e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—RXRA—prostate cancer	4.36e-06	3.88e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—VEGFA—prostate cancer	4.35e-06	3.88e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—JAK2—prostate cancer	4.35e-06	3.88e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CTNNB1—prostate cancer	4.33e-06	3.86e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KDR—prostate cancer	4.33e-06	3.86e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—STAT3—prostate cancer	4.31e-06	3.84e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CREBBP—prostate cancer	4.29e-06	3.82e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—PIK3CA—prostate cancer	4.26e-06	3.8e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NCOA3—prostate cancer	4.26e-06	3.79e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MMP9—prostate cancer	4.25e-06	3.79e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MDM2—prostate cancer	4.25e-06	3.78e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IGF1—prostate cancer	4.24e-06	3.78e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CDKN1A—prostate cancer	4.23e-06	3.77e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PTEN—prostate cancer	4.23e-06	3.76e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EGFR—prostate cancer	4.22e-06	3.76e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ESR1—prostate cancer	4.22e-06	3.76e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—COMT—prostate cancer	4.2e-06	3.74e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CD—prostate cancer	4.19e-06	3.73e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ERBB2—prostate cancer	4.19e-06	3.73e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTP1—prostate cancer	4.18e-06	3.72e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CB—prostate cancer	4.13e-06	3.68e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—AKT1—prostate cancer	4.12e-06	3.67e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—BAD—prostate cancer	4.12e-06	3.67e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ITPR1—prostate cancer	4.11e-06	3.66e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CG—prostate cancer	4.1e-06	3.65e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAP2K1—prostate cancer	4.1e-06	3.65e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CD—prostate cancer	4.07e-06	3.63e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HPGDS—prostate cancer	4.06e-06	3.62e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.04e-06	3.6e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—PIK3CA—prostate cancer	4.03e-06	3.59e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EP300—prostate cancer	4.03e-06	3.59e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SERPINE1—prostate cancer	4.03e-06	3.59e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MYC—prostate cancer	4e-06	3.57e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFB1—prostate cancer	3.99e-06	3.56e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	3.99e-06	3.55e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—APC—prostate cancer	3.99e-06	3.55e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—KRAS—prostate cancer	3.99e-06	3.55e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—prostate cancer	3.97e-06	3.54e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—NOS3—prostate cancer	3.96e-06	3.53e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTT1—prostate cancer	3.94e-06	3.51e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ACHE—prostate cancer	3.94e-06	3.51e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGF—prostate cancer	3.94e-06	3.51e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IRS1—prostate cancer	3.94e-06	3.51e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—SRC—prostate cancer	3.92e-06	3.49e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EGFR—prostate cancer	3.92e-06	3.49e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGF2—prostate cancer	3.9e-06	3.47e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.9e-06	3.47e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—TYMS—prostate cancer	3.88e-06	3.46e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—INS—prostate cancer	3.88e-06	3.46e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1B—prostate cancer	3.88e-06	3.45e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOS3—prostate cancer	3.84e-06	3.42e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GSTM1—prostate cancer	3.84e-06	3.42e-05	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—AKT1—prostate cancer	3.84e-06	3.42e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—GSK3B—prostate cancer	3.83e-06	3.41e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—VEGFA—prostate cancer	3.82e-06	3.4e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CREBBP—prostate cancer	3.8e-06	3.39e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CASP3—prostate cancer	3.8e-06	3.39e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—prostate cancer	3.8e-06	3.38e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.79e-06	3.38e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT3—prostate cancer	3.78e-06	3.37e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—prostate cancer	3.78e-06	3.36e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—INS—prostate cancer	3.77e-06	3.36e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PRKACB—prostate cancer	3.77e-06	3.36e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—LPL—prostate cancer	3.77e-06	3.36e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—JAK2—prostate cancer	3.74e-06	3.33e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.73e-06	3.32e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—KRAS—prostate cancer	3.7e-06	3.3e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCND1—prostate cancer	3.7e-06	3.3e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CREBBP—prostate cancer	3.7e-06	3.29e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CTNNB1—prostate cancer	3.66e-06	3.26e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—PIK3CA—prostate cancer	3.66e-06	3.26e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CB—prostate cancer	3.65e-06	3.25e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IGF1—prostate cancer	3.65e-06	3.25e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MDM2—prostate cancer	3.65e-06	3.25e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.64e-06	3.24e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EGFR—prostate cancer	3.63e-06	3.24e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTGS2—prostate cancer	3.62e-06	3.22e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ERCC2—prostate cancer	3.61e-06	3.22e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CD—prostate cancer	3.61e-06	3.21e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ERBB2—prostate cancer	3.6e-06	3.2e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MMP9—prostate cancer	3.59e-06	3.2e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CDKN1A—prostate cancer	3.58e-06	3.19e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PTEN—prostate cancer	3.57e-06	3.18e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NCOA2—prostate cancer	3.56e-06	3.17e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CB—prostate cancer	3.55e-06	3.16e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	3.53e-06	3.14e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MYC—prostate cancer	3.51e-06	3.13e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	3.51e-06	3.12e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFB1—prostate cancer	3.5e-06	3.12e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—AKT1—prostate cancer	3.48e-06	3.1e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	3.47e-06	3.09e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	3.47e-06	3.09e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EGFR—prostate cancer	3.43e-06	3.06e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—KRAS—prostate cancer	3.43e-06	3.06e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—prostate cancer	3.41e-06	3.04e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EP300—prostate cancer	3.41e-06	3.03e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—NOS3—prostate cancer	3.41e-06	3.03e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PIK3CA—prostate cancer	3.4e-06	3.03e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTHFR—prostate cancer	3.39e-06	3.02e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.39e-06	3.02e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGF2—prostate cancer	3.36e-06	2.99e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1B—prostate cancer	3.33e-06	2.97e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARA—prostate cancer	3.33e-06	2.97e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.31e-06	2.95e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—SRC—prostate cancer	3.31e-06	2.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOS3—prostate cancer	3.31e-06	2.95e-05	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—AKT1—prostate cancer	3.29e-06	2.93e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TP53—prostate cancer	3.29e-06	2.93e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NQO1—prostate cancer	3.28e-06	2.92e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CASP3—prostate cancer	3.26e-06	2.91e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—prostate cancer	3.26e-06	2.9e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—KRAS—prostate cancer	3.24e-06	2.89e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—prostate cancer	3.24e-06	2.89e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TH—prostate cancer	3.23e-06	2.88e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—VEGFA—prostate cancer	3.23e-06	2.87e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—JAK2—prostate cancer	3.22e-06	2.87e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT3—prostate cancer	3.19e-06	2.84e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCND1—prostate cancer	3.18e-06	2.83e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PTEN—prostate cancer	3.16e-06	2.81e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	3.15e-06	2.81e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CTNNB1—prostate cancer	3.15e-06	2.8e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CB—prostate cancer	3.14e-06	2.8e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.14e-06	2.8e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MDM2—prostate cancer	3.14e-06	2.8e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CAV1—prostate cancer	3.13e-06	2.79e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTGS2—prostate cancer	3.11e-06	2.77e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ERBB2—prostate cancer	3.1e-06	2.76e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MMP9—prostate cancer	3.08e-06	2.75e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CDKN1A—prostate cancer	3.07e-06	2.74e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PTEN—prostate cancer	3.07e-06	2.73e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	3.06e-06	2.72e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GGT1—prostate cancer	3.04e-06	2.71e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—EP300—prostate cancer	3.01e-06	2.68e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—prostate cancer	3.01e-06	2.68e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NCOA1—prostate cancer	3e-06	2.67e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—AKT1—prostate cancer	2.99e-06	2.66e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	2.98e-06	2.65e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MYC—prostate cancer	2.97e-06	2.64e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFB1—prostate cancer	2.96e-06	2.64e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.95e-06	2.63e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—prostate cancer	2.94e-06	2.62e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EP300—prostate cancer	2.92e-06	2.6e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EGFR—prostate cancer	2.9e-06	2.59e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TP53—prostate cancer	2.88e-06	2.57e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	2.87e-06	2.55e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.85e-06	2.54e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—RXRA—prostate cancer	2.85e-06	2.54e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—SRC—prostate cancer	2.84e-06	2.53e-05	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	2.84e-06	2.53e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CASP3—prostate cancer	2.81e-06	2.5e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—prostate cancer	2.81e-06	2.5e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—prostate cancer	2.79e-06	2.49e-05	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKT1—prostate cancer	2.78e-06	2.47e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—VEGFA—prostate cancer	2.77e-06	2.47e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—COMT—prostate cancer	2.74e-06	2.44e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT3—prostate cancer	2.74e-06	2.44e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—KRAS—prostate cancer	2.74e-06	2.44e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCND1—prostate cancer	2.74e-06	2.44e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTP1—prostate cancer	2.73e-06	2.43e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PTEN—prostate cancer	2.72e-06	2.42e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	2.71e-06	2.41e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—INS—prostate cancer	2.7e-06	2.4e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ITPR1—prostate cancer	2.69e-06	2.39e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MMP9—prostate cancer	2.66e-06	2.37e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	2.65e-06	2.36e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CREBBP—prostate cancer	2.64e-06	2.35e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PTEN—prostate cancer	2.64e-06	2.35e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—prostate cancer	2.64e-06	2.35e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—EP300—prostate cancer	2.59e-06	2.31e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—AKT1—prostate cancer	2.58e-06	2.29e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MYC—prostate cancer	2.55e-06	2.27e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFB1—prostate cancer	2.54e-06	2.26e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—TYMS—prostate cancer	2.54e-06	2.26e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	2.52e-06	2.24e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EP300—prostate cancer	2.52e-06	2.24e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GSTM1—prostate cancer	2.51e-06	2.24e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.51e-06	2.23e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EGFR—prostate cancer	2.49e-06	2.22e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—LPL—prostate cancer	2.46e-06	2.19e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—SRC—prostate cancer	2.45e-06	2.18e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TP53—prostate cancer	2.44e-06	2.17e-05	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKT1—prostate cancer	2.43e-06	2.17e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—VEGFA—prostate cancer	2.38e-06	2.12e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.38e-06	2.12e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—NOS3—prostate cancer	2.37e-06	2.11e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT3—prostate cancer	2.36e-06	2.1e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ERCC2—prostate cancer	2.36e-06	2.1e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KRAS—prostate cancer	2.35e-06	2.1e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—prostate cancer	2.23e-06	1.99e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PIK3CA—prostate cancer	2.23e-06	1.98e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTHFR—prostate cancer	2.22e-06	1.98e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MYC—prostate cancer	2.19e-06	1.95e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFB1—prostate cancer	2.19e-06	1.95e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.18e-06	1.95e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARA—prostate cancer	2.18e-06	1.94e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTGS2—prostate cancer	2.16e-06	1.93e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	2.16e-06	1.93e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EGFR—prostate cancer	2.15e-06	1.91e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TP53—prostate cancer	2.09e-06	1.86e-05	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKT1—prostate cancer	2.06e-06	1.83e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CAV1—prostate cancer	2.05e-06	1.82e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KRAS—prostate cancer	2.03e-06	1.81e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.92e-06	1.71e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—prostate cancer	1.92e-06	1.71e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PTEN—prostate cancer	1.89e-06	1.68e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.86e-06	1.66e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	1.86e-06	1.66e-05	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—AKT1—prostate cancer	1.82e-06	1.62e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TP53—prostate cancer	1.8e-06	1.6e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—EP300—prostate cancer	1.8e-06	1.6e-05	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKT1—prostate cancer	1.77e-06	1.57e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—INS—prostate cancer	1.76e-06	1.57e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CREBBP—prostate cancer	1.73e-06	1.54e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—prostate cancer	1.65e-06	1.47e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—AKT1—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—NOS3—prostate cancer	1.55e-06	1.38e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKT1—prostate cancer	1.52e-06	1.36e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.43e-06	1.27e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTGS2—prostate cancer	1.42e-06	1.26e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.33e-06	1.19e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PTEN—prostate cancer	1.23e-06	1.1e-05	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—EP300—prostate cancer	1.18e-06	1.05e-05	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—AKT1—prostate cancer	1.09e-06	9.69e-06	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.71e-07	7.76e-06	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—AKT1—prostate cancer	7.11e-07	6.34e-06	CbGpPWpGaD
